Pancreatic carcinoma: MR assessment of tumor invasion of the peripancreatic vessels
- PMID: 7560319
Pancreatic carcinoma: MR assessment of tumor invasion of the peripancreatic vessels
Abstract
Objective: Our goal was to determine the value of MRI in the assessment of vascular invasion in the preoperative staging of pancreatic carcinoma.
Materials and methods: In 53 consecutive patients with an established diagnosis of pancreatic ductal adenocarcinoma, SE T1-weighted and breath-hold gradient echo images at 0.5 T were obtained before and after bolus injection of Gd-DTPA. Major peripancreatic vessels were evaluated for the presence of (a) no tumor invasion, (b) contiguity with tumor, and (c) tumor encasement. All patients subsequently underwent surgery. Results of unenhanced and contrast-enhanced MRI studies were compared with the histologic findings in the resected specimens in 34 cases and with the surgical findings in 19 nonresected cases.
Results: In six patients, pathologic examination showed the presence of tumor confined to the pancreas with no vascular invasion. With MRI, five of these cases were correctly evaluated; in the remaining case, tumor-vessel contiguity was erroneously diagnosed. In 21 patients, tumor contiguity with adjacent vessels was found at pathologic examination. At MRI, 16 of these cases were correctly assessed, and 5 were understaged as tumors confined to the pancreas. Of the remaining 26 patients, 7 had vascular encasement by tumor at pathologic examination of the resected specimen; the other 19 patients had unresectable tumors encasing the adjacent vessels at surgical evaluation. MRI detected vascular encasement in 21 of these 26 cases; in the other 5, tumor contiguity was incorrectly diagnosed. The overall accuracy of MRI for determining vascular invasion was 79%.
Conclusion: MRI is a helpful method for preoperative assessment of vascular involvement due to pancreatic carcinoma.
Similar articles
-
Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coil.AJR Am J Roentgenol. 1996 Oct;167(4):997-1001. doi: 10.2214/ajr.167.4.8819400. AJR Am J Roentgenol. 1996. PMID: 8819400
-
[MRI in the evaluation of peripancreatic vessel invasion and resectability of pancreatic carcinoma].Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):846-9. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396644 Chinese.
-
[The role of magnetic resonance imaging in the preoperative evaluation of the peripancreatic vasculature in pancreas carcinoma].Rofo. 2004 Feb;176(2):239-45. doi: 10.1055/s-2004-817634. Rofo. 2004. PMID: 14872379 German.
-
Magnetic resonance imaging of thymic epithelial tumors.Crit Rev Diagn Imaging. 1996 Aug;37(3):191-259. Crit Rev Diagn Imaging. 1996. PMID: 8872410 Review.
-
[Pancreatic carcinoma presenting with invasion of the vena porta or the superior mesenteric vein: our experience and review of the literature].Minerva Chir. 2010 Dec;65(6):587-99. Minerva Chir. 2010. PMID: 21224793 Review. Italian.
Cited by
-
Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors.Ann Surg. 1997 Oct;226(4):393-405; discussion 405-7. doi: 10.1097/00000658-199710000-00001. Ann Surg. 1997. PMID: 9351708 Free PMC article.
-
CT and MR imaging patterns for pancreatic carcinoma invading the extrapancreatic neural plexus (Part II): Imaging of pancreatic carcinoma nerve invasion.World J Radiol. 2012 Jan 28;4(1):13-20. doi: 10.4329/wjr.v4.i1.13. World J Radiol. 2012. PMID: 22328967 Free PMC article.
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
-
Wall composition analysis of the human hepatic artery by intravascular ultrasound.J Med Ultrason (2001). 2008 Sep;35(3):107-11. doi: 10.1007/s10396-008-0180-4. Epub 2008 Sep 19. J Med Ultrason (2001). 2008. PMID: 27278832
-
Pancreatic cancer: can we screen? How should we stage?Curr Gastroenterol Rep. 1999 Apr;1(2):166-74. doi: 10.1007/s11894-996-0017-5. Curr Gastroenterol Rep. 1999. PMID: 10980945 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical